Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 2,174 shares at $46.65 ($101K) on 2026-05-05, disclosed to the SEC on 2026-05-06.
Open-market sale of $101k TVTX by CHIEF COMMERCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |
| TVTX | SELL | 2025-11-04 | $196K | — | Filing → |